Tenofovir is superior to entecavir for achieving complete viral suppression in HBeAg-positive chronic hepatitis B patients with high HBV DNA-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tenofovir is superior to entecavir for achieving complete viral suppression in HBeAg-positive chronic hepatitis B patients with high HBV DNA

Published:2014-01-27 Issue:6 Volume:39 Page:629-637
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Gao L.¹,Trinh H. N.²,Li J.³,Nguyen M. H.⁴

Affiliation:

1. Department of Chemistry; Stanford University; Stanford CA USA

2. San Jose Gastroenterology; San Jose CA USA

3. Palo Alto Medical Foundation; Mountain View CA USA

4. Division of Gastroenterology and Hepatology; Stanford University Medical Center; Stanford CA USA

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.12629/fullpdf

Reference33 articles.

1. Chronic hepatitis B: update 2009;Lok;Hepatology,2009

2. Hepatitis B virus infection;Lee;N Engl J Med,1997

3. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level;Chen;JAMA,2006

4. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load;Iloeje;Gastroenterology,2006

5. Hepatitis B e antigen and the risk of hepatocellular carcinoma;Yang;N Engl J Med,2002

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a reconstructed individual patient data meta-analysis;Frontiers in Pharmacology;2024-08-22

2. Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study;Clinical and Molecular Hepatology;2024-07-01

3. Tenofovir Is Associated With a Better Prognosis Than Entecavir for Hepatitis B Virus–Related Hepatocellular Carcinoma;Clinical Gastroenterology and Hepatology;2024-07

4. Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysis;Journal of Hepatology;2023-03

5. OCRELIZUMAB THERAPY IN PATIENTS WITH ANTI-HBC ANTIBODIES – A PRELIMINARY STUDY;Polski Merkuriusz Lekarski;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3